Prokarium has announced the issuance of two Notices of Allowance from the USPTO for patents that enhance its innovative cancer treatment technologies. These patents are designed to advance their mission in developing scalable therapies for bladder cancer.
Company Information
Company
Prokarium
Location
London, England, United Kingdom
About
Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prokarium ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.